Damon Runyon Funds High-Risk Cancer Studies | GenomeWeb

NEW YORK (GenomeWeb News) – The Damon Runyon Cancer Research Foundation has awarded three grants totaling more than $1.3 million to researchers pursuing high-risk cancer research involving genomics, proteomics, and metabolomics, the foundation said today.

The 2010 Damon Runyon-Rachleff Innovation Awards will give three investigators grants of $450,000, to be spread out over three years at $150,000 per year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.